[1] Wang NL, Zhang HL, Wang X, et al. Preliminary analysis on donors to National Human Brain Bank for Development and Function [J]. Journal of Clinical Neurosurgery, 2021,18(3):242-246. (in Chinese)
王乃利, 张翰林, 王雪, 等. 国家发育和功能人脑组织资源库捐献者初步分析[J]. 临床神经外科杂志,2021,18 (3):242-246.
[2] Liu F, Yin XSh, Cong C, et al. Human Brain Banking as a Convergence Platform of Neuroscience and Neuropsychiatric Research[J]. Human Brain,2022,1 (1): 71-92.
[3] Yan XX, Ma C, Bao AM, et al. Brain banking as a cornerstone of neuroscience in China[J]. Lancet Neurol,2015,14 (2):136.
[4] Kretzschmar H. Brain Banking: opportunities, challenges and meaning for the future[J]. Nat Rev Neurosci, 2009,10(1):70-78
[5] Bao AM, Wu JL. Significance of the Construction of Chinese Brain Tissue Bank and its present situation at home and abroad[J]. Journal of Diagnostics Concepts and Practice, 2018,17 (4):373-376. (in Chinese)
包爱民,吴娟利. 中国人脑组织库建设的意义及国内外现状[J]. 诊断学理论与实践,2018,17 (4):373-376.
[6] Du J, Mi ShX, Jin YCh, et al. Analysis of Human Brain Bank samples from Hebei Medical University[J]. Acta Anatomica Sinica, 2024, 55(4): 437-444. (in Chinese)
杜鹃, 米世雄, 靳玉川, 等. 河北医科大学人脑组织库样本分析[J]. 解剖学报, 2024, 55(4): 437-444.
[7] Qiu WY, Ma Ch, Bao AM, et al. Standardized operational protocol for Human Brain Banking in China[J]. Acta Anatomica Sinica,2017,48 (3):334-341. (in Chinese)
仇文颖, 马超, 包爱民, 等. 中国人脑组织库标准化操作方案[J]. 解剖学报,2017,48 (3):334-341.
[8] Qiu WY, Zhang HL, Bao AM, et al. Standardized operational protocol for Human Brain Banking in China[J]. Neurosci Bull, 2019,35 (2):270-276.
[9] Wang X, Wu JL, Wang NL, et al. Standardized operational protocol for the China Human Brain Bank Consortium[J]. Human Brain,2022,1 (1), 61-75.
[10] Sachdev PS, Blacker D, Blazer DG, et al. Classifying neurocognitive disorders: the DSM-5 approach[J]. Nat Rev Neurol,2014,10 (11):634-642.
[11] Tay L, Lim WS, Chan M, et al. New DSM-V neurocognitive disorders criteria and their impact on diagnostic classifications of mild cognitive impairment and dementia in a memory clinic setting[J]. Am J Geriatr Psychiatry,2015,23 (8):768-779.
[12] Qiu WY, Yang Q, Zhang WY, et al. The correlations between postmortem brain pathologies and cognitive dysfunction in aging and Alzheimer’s disease[J]. Curr Alzheimer Res,2018,15 (5):46-473.
[13] Yang Q, Chen K, Zhang HL, et al. Correlations between single nucleotide polymorphisms, cognitive dysfunction, and postmortem brain pathology in Alzheimer’s disease among Han Chinese[J]. Neurosci Bull,2019,35 (2):193-204.
[14] Cairns NJ, Bigio EH, Mackenzie IR, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration[J]. Acta Neuropathol,2007,114 (1):5-22.
[15] Trojanowski JQ, Revesz T, Neuropathology Working Group on MSA. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy[J]. Neuropathol Appl Neurobiol,2007,33 (6):615-620.
[16] Vonsattel JP, Myers RH, Stevens TJ, et al. Neuropathological classification of Huntington’s Disease[J]. Neuropathol Exp Neurol,1985,44 (6):559-577.
[17] Deramecourt V, Slade JY, Oakley AE, et al. Staging and natural history of cerebrovascular pathology in dementia[J]. Neurology,2012,78 (4):1043-1050.
[18] Dickson DW, Braak H, Duda JE, et al. Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria[J]. Lancet Neurology,2009,8(12):1150-1157.
[19] Schellenberg GD, Montine TJ. The genetics and neuropathology of Alzheimer’s disease[J]. Acta Neuropathol,2012,124 (3):305-323.
[20] Montine TJ, Phelps CH, Beach TG, et al. National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach[J]. Acta Neuropathol,2012,123 (1):1-11.
[21] Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson’s disease[J]. Neurobiol Aging,2003,24 (2):197-211.
[22] Del Tredici K, Braak H. Review: Sporadic Parkinson’s disease: development and distribution of α-synuclein pathology[J]. Neuropathol Appl Neurobiol,2016,42 (1):33-50.
[23] Dutra JR, Cortés EP, Vonsattel JP. Update on hippocampal sclerosis[J]. Curr Neurol Neurosci Rep,2015,15 (10):67.
[24] Jellinger KA, Attems J. Neuropathological evaluation of mixed dementia[J]. J Neurol Sci,2007,257 (1-2):80-87.
[25] Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update[J]. Acta Neuropathol,2010,119 (1):1-4.
[26] Nelson PT, Schmitt FA, Lin Y, et al. Hippocampal sclerosis in advanced age: clinical and pathological features[J]. Brain,2011,134 (Pt 5):1506-1518.
[27] Neumann M, Rademakers R, Roeber S, et al. A new subtype of frontotemporal lobar degeneration with FUS pathology[J]. Brain,2009,132 (Pt 11):2922-2931.
[28] Mckeit IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies[J]. Neurology,2017,89(1):88-100.
[29] Chen Z, Wang X, Wu JL, et al. Standardized operational protocol of human brain banking for amyotrophic lateral sclerosis[J]. Human Brain,2023,2 (1):1-8.
|